Back to Candriam S.C.A. Candriam S.C.A.

ALNYALNY
30 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in ALNYLAM PHARMACEUTICALS INC

Candriam S.C.A. holds 314,512 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $94.6M as of 2026-Q2. The position was increased (+40.2% shares). ALNY represents 0.4% of Candriam S.C.A.'s portfolio.

Current Value

$94.6M

Current Shares

314,512

Total Value Change

+$68M

Total Shares Change

+29,811

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
314,512
+40.2%
$94.6M0.4%$301.03
47
2026-Q1
Unchanged
224,330
0.0%
$74.2M0.4%$330.87
0
2025-Q4
Increased
224,330
+5.6%
$89.2M0.4%$397.65
38
2025-Q3
Decreased
212,416
-10.8%
$96.9M0.5%$456.00
0
2025-Q2
Decreased
238,084
-4.7%
$77.6M0.4%$326.09
0
2025-Q1
Decreased
249,919
-11.5%
$67.5M0.4%$270.02
0
2024-Q4
Decreased
282,407
-19.7%
$66.5M0.4%$235.31
0
2024-Q3
Increased
351,668
+0.1%
$96.7M0.6%$275.03
42
2024-Q2
Increased
351,228
+10.8%
$85.3M0.5%$243.00
47
2024-Q1
Increased
316,898
+26.6%
$47.4M0.3%$149.45
43
2023-Q4
Decreased
250,384
-23.9%
$47.9M0.3%$191.41
0
2023-Q3
Increased
328,894
+3.1%
$58.2M0.4%$177.10
36
2023-Q2
Decreased
318,894
-2.9%
$60.6M0.4%$189.94
0
2023-Q1
Increased
328,291
+2.4%
$60.5M0.4%$200.32
36
2022-Q4
Decreased
320,495
-9.2%
$76.2M0.5%$237.65
0
2022-Q3
Increased
353,048
+2.9%
$70.7M0.5%$200.16
36
2022-Q2
Increased
343,213
+13.0%
$50.1M0.4%$145.85
40
2022-Q1
Increased
303,653
+26.2%
$49.6M0.3%$163.29
43
2021-Q4
Increased
240,571
+80.8%
$40.8M0.3%$169.58
53
2021-Q3
Decreased
133,079
-23.9%
$25.1M0.2%$188.81
0
2021-Q2
Increased
174,822
+7.5%
$29.6M0.2%$169.52
37
2021-Q1
Unchanged
162,558
0.0%
$20.3M0.2%$141.19
0
2020-Q4
Decreased
162,558
-3.0%
$21.1M0.2%$129.97
0
2020-Q3
Unchanged
167,600
0.0%
$24.4M0.2%$145.60
0
2020-Q2
Decreased
167,600
-12.1%
$24.8M0.3%$148.11
0
2020-Q1
Unchanged
190,732
0.0%
$21.5M0.2%$108.85
0
2019-Q4
Increased
190,732
+0.3%
$22M0.2%$115.17
34
2019-Q3
Decreased
190,073
-50.2%
$15.3M0.2%$80.42
0
2019-Q2
Increased
381,724
+34.1%
$27.6M0.3%$72.56
44
2019-Q1
New
284,701
-
$26.6M0.3%$93.45
47

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used